$CNO

Tarasi Rocco F. III sold $226K of CNO

Tarasi Rocco F. III (Chief Marketing Officer) sold 4,808 shares of CNO Financial Group, Inc. (CNO) at $47.00 ($0.23M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tarasi Rocco F. III
Published Jun 4, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNO
Neutral
high confidence
Mentioned
$CNO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

Because the transaction is pre-arranged, it is generally less informative about near-term fundamentals; traders may treat it as a minor sentiment datapoint.

02

Market read

Insider selling disclosure with no accompanying earnings, guidance, deal, or regulatory event.

03

What to watch

The disclosure does not reveal whether the sale was part of routine diversification, tax planning, or a change in outlook; size is modest relative to typical liquidity.

Relevance 6/10Novelty 2/10Timing: Filed today; sale occurred on 2026-06-02

Background

The filing is an SEC Form 4 insider transaction by CNO’s Chief Marketing Officer, executed via an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$CNONeutralHigh confidence
Context

CNO’s CMO Tarasi Rocco F. III sold 4,808 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow rather than fundamentals.

Evidence & confidence

Form 4 insider sales are typically routine when under a 10b5-1 plan and the filing provides no accompanying company-specific news.

Market effects

Minimal—single-company insider transaction with no sector-wide read-across stated.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s risk/valuation view, potentially weighing on sentiment.

Key entities

  • CNO Financial Group, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Tarasi Rocco F. III

    Chief Marketing Officer who sold 4,808 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNOMed

California Nanotechnologies Posts 28% Revenue Growth in Q1 FY2027 as Nuclear Pivot Takes Hold

California Nanotechnologies (TSXV:CNO) reported Q1 FY2027 revenue of $917,854, up 28% from $716,553 a year earlier, for the quarter ended May 31, 2026. Adjusted EBITDA loss narrowed to $129,031 from $152,707, while net loss was $449,598. The company attributes growth to customer diversification and a nuclear supply-chain pivot tied to initial SMR component purchase orders.

$CNOHighAI 9/10

CNO Financial (CNO) Q2 2026 Earnings Call Transcript

CNO Financial Group (NYSE:CNO) reported Q2 2026 operating EPS of $1.26, up 45% year over year, and net operating income of $119.5 million. Total new annualized premiums rose 7% to a record. Full-year EPS guidance was raised to $4.60 to $4.80. The company also repurchased $60 million of shares.

$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Second Quarter 2026 Results Carmel, Ind., July 30, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its second quarter 2026 financial results: • Strong execution and momentum continues; Raising 2026 operating earni